KRKA (KRK.WA) Financials
KRK.WA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 12.3 billion | 2.5 billion |
| 2023-06-30 | 12.3 billion | 2.2 billion |
| 2023-03-31 | 12.9 billion | 2.6 billion |
| 2022-12-31 | 12.6 billion | 2.6 billion |
KRK.WA Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | 214.3 million | ? |
| 2023-06-30 | 258.8 million | ? |
| 2023-03-31 | -9.5 million | ? |
| 2022-12-31 | 478.7 million | ? |
KRK.WA Net Income
| Date | Net Income |
|---|---|
| 2023-09-30 | 302.4 million |
| 2023-06-30 | 360.0 million |
| 2023-03-31 | 415.8 million |
| 2022-12-31 | 292.9 million |
KRK.WA Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | - | - | 46.9 million |
| 2023-06-30 | - | - | 48.4 million |
| 2023-03-31 | - | - | 53.6 million |
| 2022-12-31 | - | - | 55.6 million |
KRK.WA Shares Outstanding
KRK.WA Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 114.3 million | 193.1 million | 476.5 million | - |
| 2023-06-30 | 109.8 million | 185.7 million | 469.4 million | - |
| 2023-03-31 | 115.3 million | 205.1 million | 539.3 million | - |
| 2022-12-31 | 80.5 million | 202.4 million | 537.2 million | - |
KRK.WA Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 1.9 billion | 892.3 million |
| 2023-06-30 | 2.1 billion | 881.2 million |
| 2023-03-31 | 2.1 billion | 834.3 million |
| 2022-12-31 | 2.2 billion | 854.8 million |
KRK.WA
Price: PLN540
Forward Dividend Yield: 5.43%
Payout Ratio: 71.03%
Dividend Per Share: 29.34 PLN
Earnings Per Share: 41.30 PLN
P/E Ratio: 12
Exchange: WSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 17.0 billion
Average Dividend Frequency: 1
Years Paying Dividends: 12
DGR3: 16.04%
DGR5: 19.16%
DGR10: 30.00%